+39 02 610346.1 - info@newron.com

Latest press releases

  • 9Dec
    Newron Pharmaceuticals to Request Type A FDA Meeting Prior to Unblinding of STARS Clinical Trial Data

     

  • 25Nov
    Newron Receives Second Tranche from Financing Agreement with European Investment Bank (EIB)

     

  • 19Nov
    Newron Receives FDA Rare Pediatric Disease Designation for Sarizotan for the Treatment of Rett Syndrome

     

  • 29Oct
    Newron Initiates Outreach on First Global Rett Syndrome Burden of Illness Survey in Collaboration with the Rett Community

  • 20Sep
    Newron Pharmaceuticals: Commercialization partner Meiji Seika together with Eisai announce the approval of safinamide for Parkinson’s disease in Japan

  • 12Sep
    Newron reports half-year 2019 results

     

View All

Newron share price

Events

  • 13Jan
    J.P. Morgan 38th Annual Healthcare Conference 2020

    January 13-16, 2020 - San Francisco, CA, USA

  • 16Jan
    Baader Helvea Swiss Equities Conference

    January 16-17, 2020 - Bad Ragaz – Switzerland

  • 10Feb
    BIO CEO & Investor Conference 2020

    February 10-11, 2020 - New York, NY, USA

View Event Calendar